(Credit: Roger Ashford on Shutterstock)
In A Nutshell
- Genes, not pills: People born with cholesterol-lowering genes had up to 82% lower dementia odds, but this doesn’t mean taking pills later in life provides the same protection.
- Three winners, three duds: Only genetic versions of statins, ezetimibe, and CETP drugs showed brain benefits. PCSK9 inhibitors and triglyceride-lowering targets showed no meaningful protection.
- Timing matters most: Brain protection likely needs to start decades before memory problems appear, not when someone reaches retirement age.
- Don’t change medications: This research can’t guide treatment decisions since genes work differently than pills taken in later life.
BRISTOL, England — Every night, millions of Americans take a small pill to keep their hearts healthy. Now, scientists think those same cholesterol-lowering pills might be doing something else we didn’t know about: protecting our brains.
New research looked at the genes of over one million people and found something interesting. People born with genes that naturally keep their cholesterol low had much lower chances of getting dementia later in life. It’s like nature ran its own experiment over entire lifetimes.
Unfortunately, this doesn’t mean popping a pill at 65 will have the same effect. The study looked at people who had lower cholesterol their whole lives because of their genes, not because they started taking medicine when they got older.
The Advantage Of Having ‘Natural Statins’
Led by Liv Tybjærg Nordestgaard at the University of Bristol, the researchers studied people from Denmark, the UK, and Finland. They looked at genetic information that was already collected from huge groups of people over many years. Some participants had been tracked for up to 46 years.
The numbers were impressive:
- Denmark: 122,940 people, with 5,743 developing dementia
- UK: 383,572 people, with 4,451 developing dementia
- Finland: 412,181 people, with 19,157 developing dementia
Study authors focused on genes that control cholesterol the same way popular medications do. Some people are born with a genetic “statin” of sorts that works their whole lives. Others are born with genetic versions of other cholesterol drugs.
People with the genetic equivalent of taking statins had about 76% lower odds of dementia. Those with genes mimicking another drug called ezetimibe had 82% lower odds. A third group with genes affecting something called CETP had 70% lower odds.
Not all cholesterol genes showed brain benefits. Genes mimicking PCSK9 inhibitors (expensive injectable drugs) showed no meaningful protection against dementia.
But remember: these people weren’t taking pills. Their genes were doing the work from birth.
How Cholesterol Affects Long-Term Memory
Your brain needs a constant supply of blood to work properly. Just like cholesterol can clog the arteries going to your heart, it can also clog the tiny blood vessels feeding your brain.
When brain blood vessels get clogged, small strokes happen. You might not even notice them, but they add up over decades. Eventually, they can lead to memory problems and dementia. This isn’t a new idea. More than 100 years ago, the doctor who first described Alzheimer’s disease noticed that his patients also had hardened arteries in their brains.
The genetic study, published in Alzheimer’s & Dementia, gives us the strongest evidence yet that cholesterol really does cause brain problems, not just heart problems. When people naturally have lower cholesterol their whole lives, their brains stay healthier.
What About Pills Started Later in Life?
Just because lifelong low cholesterol protects the brain doesn’t mean starting a pill at retirement age will do the same thing. Scientists have actually tried giving cholesterol pills to older people to prevent dementia. Those studies were disappointing. The pills didn’t seem to help much.
Why the difference? Probably because brain damage builds up slowly over decades. By the time someone is 70, the damage might already be done. It’s like trying to prevent a flood by building a dam after the water is already rushing toward your house. You needed to start building that dam years earlier.
If you’re already taking cholesterol medication for your heart, this research suggests you might be getting a bonus benefit for your brain too. That’s good news, but it’s not a reason to change anything about your treatment.
If you’re not taking cholesterol medication, this study doesn’t mean you should start. These drugs have side effects, and doctors prescribe them based on your overall risk of heart problems, not just to prevent dementia.
The real takeaway is bigger: protecting your brain probably needs to start much earlier than most people think.
What Scientists Still Don’t Know
This study had some important limitations. Everyone in the research was of European background, so we don’t know if the same patterns hold true for people of other ethnicities.
Also, diagnosing dementia is tricky. Hospital records don’t always tell the whole story, and many people have mixed types of brain problems as they age.
The biggest limitation is the one we keep coming back to: genes work differently than pills. Having low cholesterol from birth because of your genes is not the same as taking a pill starting in middle age.
The Bigger Picture
About 50 million people worldwide have dementia today. That number is expected to triple by 2050 as populations get older. The new drugs for Alzheimer’s disease help a little, but they’re expensive and the benefits are small.
Prevention is still our best hope. And prevention means thinking about brain health decades before memory problems start. Regular exercise, not smoking, controlling blood pressure, managing diabetes, and yes, keeping cholesterol in check all seem to matter.
The difference is timing. While it’s never too late to help your heart, protecting your brain might need to start much earlier in life.
Should You Do Anything Differently?
For most people, the answer is no. Don’t start or stop any medications based on this research. These genetic findings can’t tell us what taking a pill will do.
But the research does suggest some general principles for brain health:
- What’s good for your heart is probably good for your brain
- Prevention works better than treatment
- Starting healthy habits early in life matters more than we used to think
If you’re concerned about your cholesterol or your risk of dementia, talk to your doctor. They can help you understand your personal risks and what makes sense for your situation.
The most important thing to remember? This research gives us hope that dementia isn’t just an inevitable part of aging. Our choices throughout life might matter more than we realized.
Disclaimer: This article discusses research findings only. The studies looked at genes, not medications. Always talk to your healthcare provider about any medical decisions. They know your personal health situation best.
Paper Summary
Methodology
Researchers analyzed genetic data from five major sources: the Copenhagen City Heart Study, Copenhagen General Population Study, UK Biobank, FinnGen, and the Global Lipids Genetics Consortium. They selected genetic variants within six genes that encode targets for cholesterol-lowering medications. The analysis used Cox regression models and both one-sample and two-sample Mendelian randomization approaches. Non-HDL cholesterol served as the primary exposure, with outcomes including vascular dementia, unspecified dementia, Alzheimer’s disease, and all-cause dementia. Ischemic heart disease served as a positive control.
Results
Meta-analyses of one-sample Mendelian randomization found that per 1 mmol/L lower non-HDL cholesterol, the odds ratio for all-cause dementia was 0.24 for HMGCR (statins), 0.18 for NPC1L1 (ezetimibe), 0.97 for PCSK9 (no effect), 1.66 for ANGPTL4, 1.41 for LPL, and 0.30 for CETP. Cox regression and two-sample Mendelian randomization produced largely consistent directional results. Effects were generally stronger for vascular dementia and unspecified dementia compared to Alzheimer’s disease.
Limitations
Only individuals of European ancestry were included, limiting generalizability. Dementia diagnoses relied on clinical records and may be misclassified. Because dementia develops over decades, studies with longer follow-up would be ideal. Results represent lifelong genetic effects rather than the impact of starting medication in late life. Some genetic variants affected multiple metabolic traits, raising potential for pleiotropy.
Funding and Disclosures
Support came from the Research Council at the Capital Region of Denmark, the Independent Research Fund Denmark, and the Medical Research Council. Dr. Nordestgaard reports consultancies with multiple pharmaceutical companies. Other authors declared various research support and advisory roles detailed in the paper.
Publication Information
Nordestgaard LT, Hanson A, Sanderson E, et al. “Cholesterol-lowering drug targets reduce risk of dementia: Mendelian randomization and meta-analyses of 1 million individuals,” was published October 8, 2025 in Alzheimer’s & Dementia. doi:/10.1002/alz.70638
Comparing genes to drugs is sales talk, promoting statins early in life. Genes, in reality, act through different mechanisms, and may have multiple effects on the body and other genes. This article is a statin promo, and is funded by drug companies. It also doesn’t mention that cholesterol is essential for the brain, and is not the cause of hardened arteries, but are like a scab on artery lining that is irritated by other agents, like irritating air pollution, toxic foods, vehicle exhaust, etc. Cholesterol is the body’s scab to heal and soothe irritated membranes. Cholesterol is also necessary for steroid hormone synthesis. Statins are controversial, and cause multiple side effects which altered genes don’t cause, another reason why the comparison between pills and genes is bad. But it does help sell statins.
Exactly! Thankyou!